Median Technologies: eyonis LCS, Median Technologies' AI-Powered Software as a Medical Device for Lung Cancer Screening, Confirmed Efficacy and Safety in RELIVE Pivotal Study

All secondary endpoints required to support eyonis LCS' intended use and desired marketing claims achieved in RELIVE eyonis LCS previously met primary endpoint, achieving statistically significant...